Trial intelligence / Profile preview

Optimization and Safety Testing of Hormone Normalization Therapy

2017-000189-31Phase 3Terminated

Sponsor
Pannon Reprodukciós Intézet
Start
Mar 2017
Modality
Small Molecules, Peptides
Countries
1
01

Overview

Phase 3, single-arm trial of triptorelin in female infertility, sponsored by Pannon Reprodukciós Intézet. Primary endpoint: Serum FSH levels throughout Cycles 0, 1, 2, and 3. Started Mar 2017; status: terminated.

02

Drugs

triptorelin
03

Conditions

female infertility

Beyond the preview

Go deeper on 2017-000189-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2017-000189-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call